Outlook Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.6M | 6.6M | 0.39 |
| 2023-09-30 | $1.4M | 6.3M | 0.22 |
| 2023-06-30 | $11M | 6.1M | 1.74 |
| 2023-03-31 | $6.6M | 6.0M | 1.09 |
| 2022-12-31 | $6.1M | 5.7M | 1.08 |
| 2022-06-30 | $5.7M | 5.6M | 1.02 |
| 2022-03-31 | $10M | 5.6M | 1.78 |
| 2021-09-30 | $10M | 4.7M | 2.17 |
| 2021-06-30 | $12M | 4.6M | 2.49 |
| 2021-03-31 | $9.4M | 4.2M | 2.25 |
| 2020-12-31 | $3.1M | 2.3M | 1.31 |
| 2020-09-30 | $487k | 677k | 0.72 |
| 2020-06-30 | $692k | 536k | 1.29 |
| 2020-03-31 | $318k | 529k | 0.60 |
| 2019-12-31 | $187k | 317k | 0.59 |
| 2019-09-30 | $472k | 317k | 1.49 |
| 2019-03-31 | $361k | 49k | 7.40 |